Clinical Trials Directory

Trials / Completed

CompletedNCT00586599

Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Indiana University · Academic / Other
Sex
All
Age
7 Years – 17 Years
Healthy volunteers
Accepted

Summary

The goal in these studies will be to assess the relative levels of the Stat4 alpha and Stat4 beta isoforms in PBMCs from patients with Crohn's Disease, ulcerative colitis, celiac disease or from control patients. We hypothesize that the beta to alpha ratio will be higher in patients with active disease and that there will be a correlation between the ratio and the severity of disease.

Conditions

Interventions

TypeNameDescription
OTHERmeasurement of inflammatory markersmeasuring inflammatory markers and comparing to controls.

Timeline

Start date
2007-08-01
Primary completion
2014-06-01
Completion
2014-07-01
First posted
2008-01-04
Last updated
2015-04-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00586599. Inclusion in this directory is not an endorsement.